[HTML][HTML] Prognostic value of tumor-infiltrating lymphocytes in triple-negative breast cancers from two phase III randomized adjuvant breast cancer trials: ECOG 2197 …
Journal of clinical oncology, 2014•ncbi.nlm.nih.gov
Purpose Recent studies suggest that tumor-infiltrating lymphocytes (TILs) are associated
with disease-free (DFS) and overall survival (OS) in operable triple-negative breast cancer
(TNBC). We seek to validate the prognostic impact of TILs in primary TNBCs in two adjuvant
phase III trials conducted by the Eastern Cooperative Oncology Group (ECOG).
with disease-free (DFS) and overall survival (OS) in operable triple-negative breast cancer
(TNBC). We seek to validate the prognostic impact of TILs in primary TNBCs in two adjuvant
phase III trials conducted by the Eastern Cooperative Oncology Group (ECOG).
Abstract
Purpose
Recent studies suggest that tumor-infiltrating lymphocytes (TILs) are associated with disease-free (DFS) and overall survival (OS) in operable triple-negative breast cancer (TNBC). We seek to validate the prognostic impact of TILs in primary TNBCs in two adjuvant phase III trials conducted by the Eastern Cooperative Oncology Group (ECOG).
ncbi.nlm.nih.gov